LifeStance names Vaughn Paunovich Chief Technology Officer, effective June 9, 2025
LifeStance Health Group said Vaughn Paunovich will join as Chief Technology Officer effective June 9, 2025, succeeding Chief Digital Officer Pablo Pantaleoni, who is leaving on July 1, 2025. The filing also describes a separation agreement for Pantaleoni with severance-type payments and equity vesting, subject to a release and continued compliance with restrictive covenants.
Key points
- Vaughn Paunovich becomes Chief Technology Officer effective June 9, 2025; he previously served as EVP, Enterprise Platforms at Amwell.
- Pablo Pantaleoni's departure takes effect July 1, 2025 (the Transition Date).
- Pantaleoni will receive an amount equal to his annual base salary in two installments, 12 months of COBRA premiums, and vesting of certain restricted stock units after January 1, 2026.
- CEO Dave Bourdon said Paunovich will lead the company's end-to-end technology strategy.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 14, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.